Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSRR6 is an inhibitor of the pantetheinase vanin-1 (IC50 = 0.54 µM for the recombinant human enzyme) and is a derivative of the CoA precursor D-pantothenic acid (Item No. 17288).1 It is selective for vanin-1 over biotinidase, cathepsin B, cathepsin L, and papain (IC50s = >200 µM for all). RR6 is active against P. falciparum (IC50 = 14.5 µM).2 It reduces plasma levels of cholesterol and increases plasma levels of free fatty acids in fasted rats when administered in the drinking water at 3 mg/ml.1 RR6 decreases neointima formation and macrophage infiltration in aortic allografts in a rat model of transplant vasculopathy.3
WARNING This product is not for human or veterinary use.
1. Discovery of small molecule vanin inhibitors: New tools to study metabolism and disease. ACS Chem. Biol. 8(3), 530-534 (2013).
2. Novel pantothenate derivatives for anti-
3. Pharmacological inhibition of vanin activity attenuates transplant vasculopathy in rat aortic allografts. Transplantation 100(8), 1656-1666 (2016).